MYH9 gene

Known as: CELLULAR MYOSIN HEAVY CHAIN, TYPE A, MHA, EPSTS 
This gene is involved in both cytoskeleton modeling and cytokinesis.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
To correlate the variable clinical features of oestrogen-receptor-positive breast cancer with somatic alterations, we studied… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND MicroRNAs (miRNAs) are important regulators that play key roles in tumorigenesis and tumor progression. A previous… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2010
Highly Cited
2010
MYH9 has been proposed as a major genetic risk locus for a spectrum of nondiabetic end stage kidney disease (ESKD). We use… (More)
  • table 1
  • table 2
  • table 2
  • figure 1
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Genetic variation at the MYH9 locus is linked to the high incidence of focal segmental glomerulosclerosis (FSGS) and non-diabetic… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
African Americans have high incidence rates of end-stage renal disease (ESRD) labeled as due to hypertension. As recent studies… (More)
  • table 1
  • figure 1
  • table 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The increased burden of chronic kidney and end-stage kidney diseases (ESKD) in populations of African ancestry has been largely… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
MYH9-related disease (MYH9-RD) is a rare autosomal-dominant disorder caused by mutations in MYH9, the gene for the heavy chain of… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are autosomal dominant macrothrombocytopenias… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The autosomal dominant, giant-platelet disorders, May-Hegglin anomaly (MHA; MIM 155100), Fechtner syndrome (FTNS; MIM 153640) and… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2000
Highly Cited
2000
May-Hegglin anomaly (MHA) is an autosomal dominant macrothrombocytopenia of unclear pathogenesis characterized by… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
Is this relevant?